Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Current evidence supports substantial preclinical promise, but clinical translation remains limited by inconsistent formulations, uncertain dosing, and the need for larger human trials
PMID 22392347
Discontinuation rates due to adverse events were dose-dependent and were driven predominantly by gastrointestinal side effects
These minutes-long durations are why studied dosing for both is once-daily subcutaneous injection
US$ 24.72
US$ 28.95
US$ 29.13
US$ 22.62
US$ 23.29
